Neurogene (NGNE) Market Capitalization (2014 - 2026)
Powered by 
Analysis
Neurogene (NGNE) Market Capitalization (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Neurogene | 864.53 Mn | 864.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 709.26 Mn |
| Mar 31, 2026 | 449.68 Mn |
| Dec 31, 2025 | 439.32 Mn |
| Sep 30, 2025 | 366.85 Mn |
| Jun 30, 2025 | 314.78 Mn |
| Mar 31, 2025 | 245.87 Mn |
| Dec 31, 2024 | 339.58 Mn |
| Sep 30, 2024 | 711.37 Mn |
| Jun 30, 2024 | 616.50 Mn |
| Mar 31, 2024 | 860.40 Mn |
| Dec 31, 2023 | 9.53 Mn |
| Sep 30, 2023 | 43.85 Mn |
| Jun 30, 2023 | 46.61 Mn |
| Mar 31, 2023 | 38.79 Mn |
| Dec 31, 2022 | 28.11 Mn |
| Sep 30, 2022 | 35.36 Mn |
| Jun 30, 2022 | 56.86 Mn |
| Mar 31, 2022 | 103.67 Mn |
| Dec 31, 2021 | 265.30 Mn |
| Sep 30, 2021 | 398.28 Mn |